IBM, Tesla and Novo Nordisk are some of the stocks on the move.
Stock gainers: Novo Nordisk shares NVO nudged up by 1% as the drugmaker reported a study showing an oral version of its popular weight-loss drug works.Stock gainers: Novo Nordisk shares NVO nudged up by 1% as the drugmaker reported a study showing an oral version of its popular weight-loss drug works.IBM shares IBM eased 1% after The Wall Street Journal reported the company was close to buying cloud-based business software company Apptio for $5 billion from Vista Equity Partners.
Shares of Mercury Systems Inc. MRCY tanked 5% after the aerospace and defense company said it didn’t find any suitors to sell itself or combine with, and announced a new interim chief executive. Tesla stock TSLA fell 2% as Goldman Sachs became the latest Wall Street bank to downgrade the automaker.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Novo Nordisk says obesity pill leads to 15% weight loss; availability 'to be determined'Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills.
続きを読む »
Wimbledon to use IBM tech to power AI commentary for online highlights'This year, we're introducing new features that use AI to help fans gain more insight and access commentary through our match highlights videos.'
続きを読む »
Tesla stock drops again after Goldman Sachs downgrades, as yet another Wall Street firm slashes ratingWall Street continues to grow cautious on an astronomical surge in shares of Tesla this year, with Goldman Sachs cutting the stock to the equivalent of a...
続きを読む »
Drone Footage Shows Tesla Cybertruck Production Well UnderwayTesla is gearing up for mass Cybertruck production at its Giga Texas plant with the installation of two 9,000-pound casting presses.
続きを読む »
Tesla CEO's tiny house in Texas used as a guest homeInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
続きを読む »